Tdap Vaccination for Infant Caregivers

Tdap Vaccination for Infant Caregivers in the Pediatric Office

This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.

Study Overview

• Status: Completed
• Conditions: Pertussis; Vaccination
• Intervention / Treatment: Other: Survey

• Study Type: Observational
• Enrollment (Actual): 102

Contacts and Locations

Study Locations

• United States
  • Connecticut
    • New Haven, Connecticut, United States, 06511
      • Hospital of St. Raphael

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 64 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

18-64 year old men and women who are mothers or other infant caregivers of 2 week old infants

Description

Inclusion Criteria:

• 18-64 years old
• English or Spanish speaking

Exclusion Criteria:

• Do not speak English or Spanish

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Mothers	Other: Survey; Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.
Other Infant Caregivers; Includes fathers, grandparents, and other adults who are infant caregivers	Other: Survey; Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Maternal Tdap Vaccination Rate	At 2 week well child visit

Secondary Outcome Measures

Outcome Measure	Time Frame
Other Infant Caregiver Tdap Vaccination Rate	At 2 week well child visit

Collaborators and Investigators

• Sponsor: Yale University
• Collaborators: Saint Raphael Healthcare System
• Investigators: Principal Investigator: Deepa R Camenga, MD, Yale University; Principal Investigator: Marjorie Rosenthal, MD MPH, Yale University

Study record dates

Study Major Dates

• Study Start: June 1, 2010
• Primary Completion (Actual): December 1, 2010
• Study Completion (Actual): June 1, 2011

Study Registration Dates

• First Submitted: November 1, 2010
• First Submitted That Met QC Criteria: November 1, 2010
• First Posted (Estimate): November 3, 2010

Study Record Updates

• Last Update Posted (Estimate): July 28, 2011
• Last Update Submitted That Met QC Criteria: July 26, 2011
• Last Verified: July 1, 2011

More Information

Terms related to this study

• Keywords: Pertussis, Vaccination, Adult
• Additional Relevant MeSH Terms: Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Bordetella Infections; Gram-Negative Bacterial Infections; Bacterial Infections; Bacterial Infections and Mycoses; Whooping Cough
• Other Study ID Numbers: 1005006837